SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Stuart MJ & Nagel RL. Sickle-cell disease. Lancet 2004; 364: 13431360.
  • 2
    Tavakkoli F, Nahavandi M, Wyche MQ & Castro O. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study. Clin Ther 2005; 27: 10831088.
  • 3
    Davies S & Olujohungbe A. Hydroxyurea for sickle cell disease. Cochrane Database Syst Rev 2001: CD002202.
  • 4
    Steinberg MH, Lu ZH, Barton FB, Terrin ML, Charache S & Dover GJ. Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea. Multicenter Study Hydroxyurea. Blood 1997; 89: 10781088.
  • 5
    Platt OS, Orkin SH, Dover G, Beardsley GP, Miller B & Nathan DG. Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest 1984; 74: 652656.
  • 6
    Brun M, Bourdoulous S, Couraud PO, Elion J, Krishnamoorthy R & Lapoumeroulie C. Hydroxyurea downregulates endothelin-1 gene expression and upregulates ICAM-1 gene expression in cultured human endothelial cells. Pharmacogenomics J 2003; 3: 215226.
  • 7
    Berendt AR, Simmons DL, Tansey J, Newbold CI & Marsh K. Intercellular adhesion molecule-1 is an endothelial cell adhesion receptor for Plasmodium falciparum. Nature 1989; 341: 5759.
  • 8
    Pino P, Taoufiq Z, Nitcheu J, Vouldoukis I & Mazier D. Blood–brain barrier breakdown during cerebral malaria: suicide or murder? Thromb Haemost 2005; 94: 336340.
  • 9
    Medana IMTG. Human cerebral malaria and the blood–brain barrier. Int J Parasitol 2006; 36: 569582.
  • 10
    Pino P, Vouldoukis I, Kolb JP et al. Plasmodium falciparum-infected erythrocyte adhesion induces caspase activation and apoptosis in human endothelial cells. J Infect Dis 2003; 187: 12831290.
  • 11
    Allison AC. Malaria in carriers of the sickle-cell trait and in newborn children. Exp Parasitol 1957; 6: 418447.
  • 12
    Aidoo M, Terlouw DJ, Kolczak MS et al. Protective effects of the sickle cell gene against malaria morbidity and mortality. Lancet 2002; 359: 13111312.
  • 13
    Muanza K, Gay F, Behr C & Scherf A. Primary culture of human lung microvessel endothelial cells: a useful in vitro model for studying Plasmodium falciparum-infected erythrocyte cytoadherence. Res Immunol 1996; 147: 149163.
  • 14
    Trager W. Cultivation of malaria parasites. Meth Cell Biol 1994; 45: 726.
  • 15
    Ockenhouse CF, Ho M, Tandon NN et al. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis 1991; 164: 163169.
  • 16
    Goodyer ID, Johnson J, Eisenthal R & Hayes DJ. Purification of mature-stage Plasmodium falciparum by gelatine flotation. Ann Trop Med Parasitol 1994; 88: 209211.
  • 17
    Udeinya IJ, Schmidt JA, Aikawa M, Miller LH & Green I. Falciparum malaria-infected erythrocytes specifically bind to cultured human endothelial cells. Science 1981; 213: 555557.
  • 18
    Rest JR. Cerebral malaria in inbred mice. I. A new model and its pathology. Trans R Soc Trop Med Hyg 1982; 76: 410415.
  • 19
    Eckwalanga M, Marussig M, Tavares MD et al. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Proc Natl Acad Sci USA 1994; 91: 80978101.
  • 20
    Idro R, Jenkins NE & Newton CR. Pathogenesis, clinical features, and neurological outcome of cerebral malaria. Lancet Neurol 2005; 4: 827840.
  • 21
    Jimenez B, Volpert OV, Crawford SE, Febbraio M, Silverstein RL & Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat Med 2000; 6: 4148.
  • 22
    Desjardins RE, Canfield CJ, Haynes JD & Chulay JD. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 1979; 16: 710718.
  • 23
    Holland KP, Elford HL, Bracchi V, Annis CG, Schuster SM & Chakrabarti D. Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives. Antimicrob Agents Chemother 1998; 42: 24562458.
  • 24
    Kinney TR, Helms RW, O’Branski EE et al. Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group. Blood 1999; 94: 15501554.
  • 25
    Yan JH, Ataga K, Kaul S et al. The influence of renal function on hydroxyurea pharmacokinetics in adults with sickle cell disease. J Clin Pharmacol 2005; 45: 434445.
  • 26
    Pasvol G, Weatherall DJ & Wilson RJ. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature 1977; 270: 171173.
  • 27
    Shear HL, Grinberg L, Gilman J et al. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 1998; 92: 25202526.
  • 28
    Pasvol G, Weatherall DJ, Wilson RJ, Smith DH & Gilles HM. Fetal haemoglobin and malaria. Lancet 1976; 1: 12691272.
  • 29
    Friedman MJ. Oxidant damage mediates variant red cell resistance to malaria. Nature 1979; 280: 245247.